514
Views
29
CrossRef citations to date
0
Altmetric
Adherence

Optimizing the Inhalation Flow and Technique Through Metered Dose Inhalers of Asthmatic Adults and Children Attending a Community Pharmacy

, PH.D. & , PH.D.
Pages 505-513 | Published online: 15 Apr 2013

References

  • Everard ML, Devadason SG, Summers QA, Lesouef PN. Factors affecting total and respirable dose delivered by a salbutamol metered-dose inhaler. Thorax 1995; 50(7):746–749.
  • Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenbergf J, Barnes PJ. Importance of inhaler devices in the management of airway disease. Respir Med 2008; 102(1):10–19.
  • Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenergic bronchodilator be inhaled. Eur J Respir Dis 1981; 62(1):3–21.
  • Everard ML. Role of inhaler competence and contrivance in “difficult asthma”. Paediatr Respir Rev 2003; 4(2):135–142.
  • Crompton GK. The adult patients difficulties with inhalers. Lung 1990; 168:658–662.
  • Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic-children. Allergy 1986; 41(2):118–124.
  • Lahdensuo A, Muittari A. Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique. Eur J Respir Dis 1986; 68(5):332–335.
  • Epstein SW, Manning CPR, Ashley MJ, Corey PN. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 1979; 120(7):813–816.
  • Pauwels R, Newman S, Borgstrom L. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. Eur Respir J 1997; 10(9):2127–2138.
  • Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 1982; 63:101–104.
  • Ganderton D. General factors influencing drug delivery to the lung. Respir Med 1997; 91:13–16.
  • Goldberg IS, Lourenco RV. Deposition of aerosols in pulmonary disease. Arch Intern Med 1973; 131(1):88–91.
  • Clarke SW, Pavia D, Newman SP. Influence of different inhalation modes on the efficacy of pressurized aerosol bronchodilators. Eur J Respir Dis 1982; 63:79–80.
  • Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers. Chest 1981; 80(6):911–915.
  • Hindle M, Newton DAG, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax 1993; 48(6):607–610.
  • Newman S, Steed K, Hooper G, Kallen A, Borgstrom L. Comparison of gamma-scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulfate delivered by pressurized metered-dose inhaler. Pharm Res 1995; 12(2):231–236.
  • Farr SJ, Rowe AM, Rubsamen R, Taylor G. Aerosol deposition in the human lung following administration from a microprocessor-controlled pressurized metered-dose inhaler. Thorax 1995; 50(6):639–644.
  • Al-Showair RA, Pearson SB, Chrystyn H. The potential of a 2tone trainer to help patients use their metered-dose inhalers. Chest 2007; 131(6):1776–1782.
  • Chrystyn H. Effects of device design on patient compliance: Comparing the same drug in different devices. Respir Drug Deliv Eur 2009; 1:105–116.
  • Horsley MG, Bailie GR. Risk-factors for inadequate use of pressurized aerosol inhalers. J Clin Pharm Therapeut 1988; 13(2):139–143.
  • Burkhart PV, Rayens MK, Bowman RK. An evaluation of children’s metered-dose inhaler technique for asthma medications. Nurs Clin North Am 2005; 40(1):167–182.
  • Kamps AWA, van Ewijk B, Roorda RJ, Brand PLP. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 2000; 29(1):39–42.
  • Sestinti P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, Canessa PA, Neri M, Melani AS, Grp AE. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med Depos Clearance Effects Lung 2006; 19(2):127–136.
  • Shim C, Williams MH. The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 1980; 69(6):891–894.
  • Walia M, Paul L, Satyavani A, Lodha R, Kalaivani M, Kabra SK. Assessment of inhalation technique and determinants of incorrect performance among children with asthma. Pediatr Pulmonol 2006; 41(11):1082–1087.
  • Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37(6):1308–1331.
  • Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J 1999; 14(1):32–38.
  • Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996; 5(1):35–46.
  • Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996; 5(1):27–34.
  • Pearson M, Bucknall C. Measuring clinical outcome in asthma: A patient-focused approach. Royal college of physicians, london (report). Report. 1999.
  • Thomas M, Gruffydd-Jones K, Stonham C, Ward S, Macfarlane TV. Assessing asthma control in routine clinical practice: Use of the royal college of physicians “3 questions”. Prim Care Respir J 2009; 18(2):83–88.
  • Keating GM, Faulds D. Airmax (tm)(1)—A multi-dose dry powder inhaler. Drugs 2002; 62(13):1887–1895.
  • Dolovich M. Aerosol delivery to children: What to use, how to choose. Pediatr Pulmonol 1999;Supplement 18: 79–82.
  • Larsen JS, Hahn M, Ekholm B, Wick KA. Evaluation of conventional press-and-breathe metered-dose inhaler technique in 501 patients. J Asthma 1994; 31(3):193–199.
  • Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105(6):930–938.
  • Tomlinson HS, Corlett SA, Allen MB, Chrystyn H. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge. Br J Clin Pharmacol 2005; 60(6):605–610.
  • Savage I, Goodyer L. Providing information on metered dose inhaler technique: Is multimedia as effective as print? Fam Pract 2003; 20(5):552–557.
  • Bateman ED, Bousquet J, Braunstein GL. Is overall asthma control being achieved? A hypothesis-generating study. Eur Respir J 2001; 17(4):589–595.
  • Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality-of-life in asthma. Am Rev Respir Dis 1993; 147(4):832–838.
  • GINA. Global strategy for asthma management and prevention, global initiative for asthma (gina) [online]. [01 August 2009]. Available at: http://www.ginasthma.org/
  • British guideline on the management of asthma. A national clinical guideline [online] [database on the Internet]. 2009 [cited 01 August 2009]. Available at: http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Asthma/Guidelines/Asthma_fullguideline_2009.pdf
  • Haughney J, Price D, Kaplan A, Chstyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, Tunsater A, Bjermer L. Achieving asthma control in practice: Understanding the reasons for poor control. Respir Med 2008; 102(12):1681–1693.
  • Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, Haughney J, Henrichsen SH, Kaplan A, Langhammer A, Ostrem A, Thomas M, van der Molen T, Virchow JC, Williams S. Can asthma control be improved by understanding the patient’s perspective?. BMC Pulm Med 2007; 7:8.
  • Garris C, Schatz M, Guilbert T, Davis EA, Bonus T, Bonafede M. Asthma control is predictive of health-related quality of life: Survey using the asthma control test (tm) and childhood asthma control test (tm). J Allergy Clin Immunol 2008; 121(2):S149–S149.
  • Schatz M, Mosen DM, Kosinski M, Vollmer WM, Magid DJ, O’Connor E, Zeiger RS. The relationship between asthma-specific quality of life and asthma control. J Asthma 2007; 44(5):391–395.
  • Pharmaceutical Services Negotiating Committee. The pharmacy contract. 2012. [cited 12 September 2012]. Available at: http://www.psnc.org.uk/pages/introduction.html
  • Centre for Pharmacy Postgraduate Education. Targeting your MURs more effectively. 2012. [cited 12 September 2012]. Available at: http://www.cppe.ac.uk/learning/Details.asp?TemplateID=TargetMUR-G-00&Format=G&ID=130&EventID=41122

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.